Navigation Links
O.R. Special Procedure Apron Lead Free

ProductsO.R. Special Procedure Apron Lead Free
Company Wolf X-ray Corporation
Item O.R. Special Procedure Apron Lead Free
Features 
  • All Our Aprons Are Available in Fashionable Colors
  • Exteriors Are Finished In Water Repellent and Stain Resistant Taffeta
  • All Seams Are Reinforced With Double Stitching For Years of Dependable Service
  • Our Lead Equivalency Material Is The Lightest Available
  • Description The O.R. Special Protective Apron is made to be worn between a scrubsuit and a sterile gown. Uniquely it can be removed without contaminating the sterile field. Reaching through the back of the gown, the velcro fasteners are released, and the protective apron will fall to the floor and the sterility remains unaffected.
    Info Wolf X-ray Corporation
    Customer Service: (800) 356-9729
    Web site: http://www.wolfxray.com/

    Related medicine products :

    1. Specialist Direct Ophthalmoscope
    2. The Natural-Hip Family - Specialty Porous Collared HA
    3. The Natural-Hip Family - Specialty Porous collarless HA
    4. SP-1 Special Procedure Wrap Around Coat Apron.
    5. MSP-3 Special Procedure wrap-around with Integrated Wide Belt
    6. Integra Epilepsy Specialty Electrodes
    7. Special Procedure Apron
    8. Front Closing Special Procedure Apron
    9. O.R. Special Procedure Apron
    10. SPP-1 Special Procedure Poncho Type
    11. O.R. Special Procedure Apron with Collar
    Buratto Insertion Forceps - Angled
    Hydroview Insertion Forceps - Titanium
    Hydro Insertion Forceps
    Kellan Lens Inserter Forceps
    Medicine Products:
    (Date:12/5/2009)... , NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ ...erious and often deadly blood cancers. Research pr...erican Society of Hematology introduces potential ...ods for patients suffering from acute promyelocyti... lymphoblastic leukemia, and myelofibrosis that ar...
    (Date:12/5/2009)... AVIVA today announced the launch of...ational private medical insurance plan which follo...nt. In addition to offering customers the flexibil...it their needs and budgets, International Solution...mplement those already offered in their country of...
    (Date:12/4/2009)...NEW YORK, Dec. 4 Care I...e "Company") today announced that its Board of Dir...of common stock. The dividend is payable on Decem...ecember 14, 2009. ,, About Care Investment ...estate investment and finance company investing in...
    (Date:12/4/2009)...WASHINGTON, Dec. 4 The ... Aging (AAHSA) applauds the Senate for ensuring th...CLASS) provisions remain in the final health refor... for providing support to elders, people with disa...Senate to pass a health care reform bill that will...
    (Date:12/4/2009)..., ANAHEIM, Calif., Dec. 4 Pamela ...hcare, was selected as a finalist for the "Chief I...scent,s business with the power of cloud computing...ir innovative usage of Salesforce CRM or the Force...uccess to their sales, marketing, partner, service...
    Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
    ... Colorado Court of Appeals handed,State Farm Mutua...ng a,trial-court ruling supporting the insurance g...mbursements of medical costs. The ruling, issued ...unilaterally reduced after the insurance,company p...
    ...rogen Pharmaceuticals,Limited (ASX: PGL; Nasdaq: P...-cancer drug PI-88 has been awarded Fast Track sta.... The fast track designation has been granted,to P... Under the FDA Modernization Act of 1997, the fas...
    ... Benjamin England,Special Counsel with Jones Walke...ture, Rural Development, Food and Drug Administrat...on Appropriations, on Tuesday, September,25, 2007 ...ategic Plan that relates to the import of food, dr...
    ...24 While most patients and physicians believe its...xam, theres growing debate about this conventional...ue of the Archives of Internal Medicine raises ser... the number, cost and content of preventive health...
    ...epressed, distraught were seldom questioned, study...s) -- Pointing to a disconnect between doctors and...ests that large numbers of physicians fail to spot...r a similar disorder. , Only 36 percent of the doc...
    ... Today, Speaker of the,House Nancy Pelosi (D-CA) a...d Louise Slaughter (D-NY), introduced the Coordina...7. This legislation would establish a,national pub...ards, and increase funding for locally-based pilot...
    Other Medicine News:Health News:Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces 2Health News:Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces 3Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 2Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 3Health News:Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee 2Health News:New study likely to fuel debate over annual physical exams 2Health News:New study likely to fuel debate over annual physical exams 3Health News:Doctors Often Fail to Spot Suicidal Patients 2Health News:Doctors Often Fail to Spot Suicidal Patients 3Health News:Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation 2
    (Date:12/3/2009)...DALE, Pa., Dec. 3 Radiology imagin...-record integration capabilities at the November 2... The Connect.PACS(TM) product, enabling the fir... is the latest release in the company,s newly bran...Photo: http://www.newscom.com/cgi-bin/prnh/20091...
    (Date:12/3/2009)...RSHOLM, Denmark and SAN DIEGO, California, Decembe...lly Inhibits miR-122, a microRNA Important for,Hep...Reducing Hepatitis C,Virus in the Bloodstream in C... C Virus , - SPC3649 Demonstrates Efficac...ous Adverse Events in the Treated Animals - Signal...
    (Date:12/3/2009)...ec. 3 In response to th...tion technologies in the evolving healthcare deliv...ter for Health Informatics (DCHI) to provide a cam...e an innovative interdisciplinary approach to educ...ians, nurses and healthcare administrators with an...
    Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Par Pharmaceutical Receives Final Approval to Market Generic Ultram 28R 29 ER 6276 1Par Pharmaceutical Receives Final Approval to Market Generic Ultram 28R 29 ER 6276 2Lilly Surpasses United Way 2009 Campaign Goal 6272 1Lilly Surpasses United Way 2009 Campaign Goal 6272 2Lilly Surpasses United Way 2009 Campaign Goal 6272 3Raleigh Day Spa Blue Water Spa Raffles Off 2410 000 in Day Spa Packages for Contributing to Raleigh Food Drive 61407 1Raleigh Day Spa Blue Water Spa Raffles Off 2410 000 in Day Spa Packages for Contributing to Raleigh Food Drive 61407 2